BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

CIK: 0001040508 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $3,913,774 (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 33.1%

Value ($000) $1,296,817 Shares 40,538,196 Est. Cost $17.18 Unrealized +72.6%

— MICHAELS COS INC 26.6%

Value ($000) $1,040,667 Shares 52,798,929 Est. Cost $17.48 Unrealized —

IQV IQVIA HLDGS INC 13.5%

Value ($000) $529,995 Shares 5,402,050 Est. Cost $101.80 Unrealized -0.7%

SGRY SURGERY PARTNERS INC 11.6%

Value ($000) $453,714 Shares 26,455,651 Est. Cost $14.30 Unrealized +8.9%

— ATENTO S A 9.7%

Value ($000) $378,461 Shares 48,520,671 Est. Cost $10.45 Unrealized —

— VERITIV CORP 4.3%

Value ($000) $167,927 Shares 4,283,840 Est. Cost $50.06 Unrealized —

— FRANKS INTL N V 1.2%

Value ($000) $46,193 Shares 8,506,930 Est. Cost $12.31 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
G	GENPACT LIMITED	40,538,196	$1,296,817	33.1%	$17.18	+72.6%	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$1,040,667	26.6%	$17.48	—	COM	59408Q106
IQV	IQVIA HLDGS INC	5,402,050	$529,995	13.5%	$101.80	-0.7%	COM	46266C105
SGRY	SURGERY PARTNERS INC	26,455,651	$453,714	11.6%	$14.30	+8.9%	COM	86881A100
—	ATENTO S A	48,520,671	$378,461	9.7%	$10.45	—	SHS	L0427L105
—	VERITIV CORP	4,283,840	$167,927	4.3%	$50.06	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$46,193	1.2%	$12.31	—	COM	N33462107